Blogs » Health » mRNA Vaccines and Therapeutics Market Share, Size | Report 2028

mRNA Vaccines and Therapeutics Market Share, Size | Report 2028

  • IMARC Group, a leading market research company, has recently releases report titled “mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global mRNA vaccines and therapeutics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

    Report Highlights

    How big is the mRNA vaccines and therapeutics market?

    Report Attributes Details Market Size in 2022 US$ 56.1 Billion Market Forecast in 2028 US$ 66.2 Billion Growth rate (2023 to 2028) CAGR of 2.9% Base Year of the Analysis 2022 Forecast Period 2023-2028

    What is mRNA vaccines and therapeutics?

    Messenger ribonucleic acid or mRNA vaccines and therapeutics refer to types of vaccines and formulations that use a copy of a molecule, known as messenger RNA, to create an immune response. They are of several types, including self-amplifying, in vivo self-replicating, non-replicating, in vitro dendritic cell non-replicating mRNA, etc. mRNA vaccines and therapeutics combine the desirable immunological properties and are produced in laboratories employing mammalian cells. They trigger virus-detecting immune sensors and build viral antigen proteins within the cells when injected into the body, thereby enhancing the body’s immunity by improving B- and T-cell responses. As a result, mRNA vaccines and therapeutics find extensive utilization in hospitals, clinics, and research organizations across countries.

    Request for a free sample copy of this report:

    What are the growth prospects and trends in the mRNA vaccines and therapeutics industry?

    The expanding prevalence of diabetes, cancer, tuberculosis, cardiovascular diseases (CVDs), etc., is among the key factors driving the global mRNA vaccines and therapeutics market. In addition to this, the escalating demand for effective medicines and treatments for influenza, Ebola, Human Immunodeficiency Virus (HIV), etc., is also positively influencing the market growth. Moreover, the increasing enhancements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are acting as another significant growth-inducing factor. In line with this, the inflating investments by leading pharmaceutical companies in mRNA technologies that can combine multiple molecules into a therapeutic medicine are further stimulating the market growth. Apart from this, the elevating research and development (R&D) projects in the field of biotechnology and the growing improvements in healthcare technologies are anticipated to fuel the global mRNA vaccines and therapeutics market over the forecasted period.

    What is included in market segmentation?

    The report has segmented the market into the following categories:

    Breakup by Vaccine Type:

    • Self-amplifying mRNA-Based Vaccines
    • Conventional Non-Amplifying mRNA-Based Vaccines

    Breakup by Treatment Type:

    • Bioengineered Vaccine
    • Gene Therapy 
    • Gene Transcription 
    • Cell Therapy
    • Monoclonal Antibody
    • Others

    Breakup by Vaccine Manufacturing:

    • In-House
    • Out-Sourced

    Breakup by Application:

    • Cancer
    • Infectious Disease
    • Gene Editing
    • Protein Replacement

    Breakup by End-User:

    • Hospitals and Clinics
    • Research Organizations
    • Others

    Breakup by Region:

    • North America (U.S. & Canada)
    • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
    • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
    • Latin America (Brazil, Mexico)
    • Middle East & Africa

    Who are the key players operating in the industry?

    The report covers the major market players including:

    • Arcturus Therapeutics Inc.
    • BioNTech SE
    • CureVac AG
    • eTheRNA immunotherapies NV
    • ethris GmbH
    • GlaxoSmithKline PLC
    • Moderna Therapeutics Inc.
    • Translate Bio Inc.
    • Argos Therapeutics, Inc.
    • Sangamo Therapeutics Inc.
    • Pfizer Inc

    Ask Analyst for Customization and Browse full report with TOC & List of Figure:

    If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

    About Us

    IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

    IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

    Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

    Contact US

    IMARC Group

    134 N 4th St. Brooklyn, NY 11249, USA

    USA: +1-631-791-1145 | Asia: +91-120-433-0800


    Follow us on Twitter: @imarcglobal